We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
- Authors
Uchida, Hideo; Downing, James R; Miyazaki, Yasushi; Frank, Richard; Zhang, Jin; Nimer, Stephen D
- Abstract
A cytogenetically cryptic (12;21) translocation is the most common molecular abnormality identified in childhood acute lymphoblastic leukemia (ALL), and it generates a chimeric TEL-AML1 protein. Fusion of the Helix-Loop-Helix (HLH) (also called the pointed) domain of TEL to AML1 has been suggested to convert AML1 from a transcriptional activator to a repressor. To define the structural features of this chimeric protein required for repression, we analysed the transcriptional activity of a series of TEL-AML1 mutants on the AML1-responsive interleukin-3 (IL-3) promoter, a potentially relevant gene target. Our results demonstrate that TEL-AML1 represses basal IL-3 promoter activity in lymphoid cells, and deletion mutant analysis identified three distinct domains of TEL-AML1 that are required for repression; the HLH (pointed) motif contained in the TEL portion of TEL-AML1, and both the runt homology domain (Rhd) and the 74 amino acids downstream of the Rhd that are present in the AML1 portion of the fusion protein. Although AML1B (and a shorter AML1 isoform, AML1A) have transcriptional activating activity on the IL-3 promoter, fusion of the AML1 gene to the TEL gene generates a repressor of IL-3 expression. Consistent with this activity, freshly isolated human ALL cells that contain TEL-AML1 do not express IL-3.
- Subjects
TRANSCRIPTION factors; INTERLEUKIN-3; PROTEINS
- Publication
Oncogene, 1999, Vol 18, Issue 4, p1015
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/sj.onc.1202383